Amedeo's Top 20

Amedeo Smart

Independent Medical Education

11 November 2024

Multidisciplinary Journal Club

  1. Rayner DG, Ferri DM, Guyatt GH, O'Byrne PM, et al.
    Inhaled Reliever Therapies for Asthma: A Systematic Review and Meta-Analysis.
    JAMA 2024.

  1. Genereux P, Schwartz A, Oldemeyer JB, Pibarot P, et al.
    Transcatheter Aortic-Valve Replacement for Asymptomatic Severe Aortic Stenosis.
    N Engl J Med 2024.

  2. Couzin-Frankel J.
    Alzheimer's drug approvals create prescribing dilemmas.
    Science 2024;386:472-473.

  3. Jairath V, Acosta Felquer ML, Jaihyun Cho R.
    IL-23 inhibition for chronic inflammatory disease.
    Lancet 2024;404:1679-1692.

  4. Ciria R, Ivanics T, Aliseda D, Claasen M, et al.
    Liver transplantation for primary and secondary liver tumours. patient-level meta-analyses compared to unos conventional indications.
    Hepatology 2024.

  1. Bliddal H, Bays H, Czernichow S, Udden Hemmingsson J, et al.
    Once-Weekly Semaglutide in Persons with Obesity and Knee Osteoarthritis.
    N Engl J Med 2024;391:1573-1583.

  2. Touijer KA, Vertosick EA, Sjoberg DD, Liso N, et al.
    Pelvic Lymph Node Dissection in Prostate Cancer: Update from a Randomized Clinical Trial of Limited Versus Extended Dissection.
    Eur Urol 2024.

  3. Iqbal J, Inghirami G, Chan WC.
    New insights into the biology of T-cell lymphomas.
    Blood 2024;144:1873-1886.

  4. McGuigan MC, Hadjicosti R, Cameron AJ, Coats M, et al.
    The Surveillance Strategy for Intraductal Pancreatic Mucinous Neoplasms: Criteria for Discontinuation.
    Ann Surg 2024.

  5. Turner NC, Im SA, Saura C, Juric D, et al.
    Inavolisib-Based Therapy in PIK3CA-Mutated Advanced Breast Cancer.
    N Engl J Med 2024;391:1584-1596.

  1. Bailon L, Puertas MC, Garcia-Guerrero MC, Moraes-Cardoso I, et al.
    Impact of Dolutegravir plus Lamivudine as First-Line Antiretroviral Treatment on HIV-1 Reservoir and Inflammatory Markers in Peripheral Blood.
    J Infect Dis 2024.

  2. Thompson RR, Kim S, Pelissari DM, Harada LO, et al.
    High mortality rates among individuals misdiagnosed with tuberculosis: a matched retrospective cohort study of individuals diagnosed with tuberculosis in Brazil.
    J Infect Dis 2024.

  3. de Leval L, Gaulard P, Dogan A.
    A practical approach to the modern diagnosis and classification of T- and NK-cell lymphomas.
    Blood 2024;144:1855-1872.

  4. Eni-Olutu A, Mackie NE, Glenn J, Bailey A, et al.
    Emerging integrase resistance in an international perinatal virtual clinic.
    AIDS 2024.

  5. Kawano-Dourado L, Kristianslund EK, Zeraatkar D, Jani M, et al.
    Proactive therapeutic drug monitoring of biologic drugs in adult patients with inflammatory bowel disease, inflammatory arthritis, or psoriasis: a clinical practice guideline.
    BMJ 2024;387:e079830.

  1. Allen I, Hassan H, Walburga Y, Huntley C, et al.
    Second Primary Cancer Risks After Breast Cancer in BRCA1 and BRCA2 Pathogenic Variant Carriers.
    J Clin Oncol 2024.

  2. Kochhar GS, Khataniar H, Hashash JG, Tabaku F, et al.
    Comparative Effectiveness of Ozanimod and Vedolizumab as First-Line Advanced Therapies in Ulcerative Colitis: A Propensity-Matched Cohort Analysis.
    Inflamm Bowel Dis 2024.

  3. Barone Gibbs B, Perera S, Huber KA, Paley JL, et al.
    Effects of Sedentary Behavior Reduction on Blood Pressure in Desk Workers: Results From the RESET-BP Randomized Clinical Trial.
    Circulation 2024;150:1416-1427.

  4. Hong N, Shin S, Kim H, Cho SJ, et al.
    Romosozumab following denosumab improves lumbar spine bone mineral density and trabecular bone score greater than denosumab continuation in postmenopausal women.
    J Bone Miner Res 2024.

  5. Stieglis R, Verkaik BJ, Tan HL, Koster RW, et al.
    Association Between Delay to First Shock and Successful First-Shock Ventricular Fibrillation Termination in Patients With Witnessed Out-of-Hospital Cardiac Arrest.
    Circulation 2024.


more..

Privacy Policy